Silverstone P

University of Alberta

1 paper

ArticleKetamine

A 28-Day, Randomized, Controlled, Single-Blind, Phase 2 Study in Treatment-Resistant Major Depressive Disorder (TRD) Patients Receiving Intranasal Esketamine Comparing Addition of Almond Therapy TM with Treatment-as-Usual (TAU)

Chue P, Silverstone P, Hillier T +6

Europe PMC2023